Sirolimus Therapy for Angiomyolipoma in Tuberous Sclerosis and Sporadic Lymphangioleiomyomatosis: A Phase 2 Trial - Concepedia

Concepedia

Publication | Open Access

Sirolimus Therapy for Angiomyolipoma in Tuberous Sclerosis and Sporadic Lymphangioleiomyomatosis: A Phase 2 Trial

DOI Full Paper Access

313

Citations

24

References

2011

Year

D. M. Davies, Petrus J. de Vries, Simon R. Johnson, Deborah L. McCartney, Jane A. Cox, Andreas L. Serra, Peter Watson, Christopher J. Howe, Timothy C. Doyle, Kate Pointon,

Clinical Cancer Research

Abstract

This study showed sustained regression of renal angiomyolipomas in patients with tuberous sclerosis or sporadic LAM receiving 2 years of sirolimus treatment. Possible effects on pulmonary function and neurocognition require further investigation.

References

	Year	Citations

Page 1